Mary Beth Navarra, RN, MBA, chief patient safety officer for McKesson Provider Technologies announced, McKesson will team up with Clorox to offer jointly-developed disinfection protocols in conjunction with McKesson's Patient Care Advantage solution. The solution, which drives a "one patient, one care team, one plan" approach to care delivery, is designed to enable hospitals to provide safer, more efficient care.

Siemens Healthcare has announced its first molecular imaging biomarker production facility in Chennai, India. The facility enable the healthcare providers in and around Chennai to access the positron emission tomography

Toshiba America Medical Systems, Inc. has received FDA clearance for two new CT clinical applications that will improve throughput and enhance workflow, while further reducing contrast and radiation dosage. The applications, SURECardio™ Prospective and Variable Helical Pitch (vHP), are available for new Toshiba AquilionTM 32- and 64-slice CT systems.

Boston Scientific Corporation has received CE Mark approval of its ACUITY® Spiral left ventricular lead for use with cardiac resynchronization therapy defibrillators and cardiac resynchronization therapy pacemakers, both of which treat heart failure.

Pioneer Surgical Technology, Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its LowTop™ pedicle screw system to treat a variety of spinal disorders.

Lundy Healthcare has acquired MediMech, the UK’s leading medical equipment refurbishment service providers.  A critical milestone in Lundy’s ongoing growth strategy, this acquisition further cements Lundy’s position as the principal player in the used medical imaging equipment industry, providing an exceptionally diverse portfolio of project management and technical services.

A Web-based application for low volume, single site imaging organizations

The search engine Google has announced plans for a healthcare Web site, which will allow patients to share their medical records with various providers to ensure a more accurate exchange of relevant data.

Some medical devices such as implantable cardiac defibrillators and pacemakers are now equipped with wireless technology, allowing for remote device checks and freeing patients from repeated doctor visits. But this convenience may come with unanticipated risks.

The Approvals include CONFIENT™ ICD, LIVIAN™ CRT-D and upgraded LATITUDE® Patient Management System

The Technology Research for Independent Living (TRIL) Centre has launched the TRIL Clinic at St James's Hospital in Dublin.

The group said it was the latest evolution of the TRIL Centre, supported by Intel and the Industrial Development Agency (IDA) Ireland, which aims to discover and deliver technology solutions that support independent ageing.

Abbott Laboratories Inc. (ABT) has received Food and Drug Administration approval for a continuous glucose-monitoring system that allows constant tracking of blood-sugar levels to help diabetes patients manage the disease.

In a  federal panel meeting  a propose of  Amgen Inc. drug to treat a rare blood-platelet illness, and sales restrictions would be included out of concern that the drug might contribute to other serious blood disorders.

Schering-Plough has announced a submission to the U.S. Food and Drug Administration (FDA) of a New Drug Application (NDA) for ZEGERID(R) (omeprazole/sodium bicarbonate) in the dosage strength of 20 mg of omeprazole as a branded over-the-counter (OTC) product to treat frequent heartburn.

Committee Recommends FDA Approve Novel Anesthesia Drug to Reverse Muscle relaxation within Minutes

Schering-Plough  announced today  that the U.S. Food and Drug Administration (FDA) Advisory Committee on Anesthetics and Life Support has recommended sugammadex for approval. After reviewing data on the safety and efficacy of the medication, the committee unanimously recommended approval of the company's application for marketing.

Amgen Inc. has received  the Food and Drug Administration approved updated safety information, including an updated boxed label warning that certain anemia drugs like Amgen's Aranesp and Epogen shorten overall survival or time-to-tumor progression in some cancer patients.

Wyeth received the US Food and Drug Administration(FDA) approval for Desvenlafaxine succinate (Pristiq™ ) a novel, once-daily serotonin-norepinephrine reuptake inhibitor (SNRI),for  the treatment of adult patients with major depressive disorder (MDD).

The Food and Drug Administration has announced, that it found unidentified contaminant  in batches of the active ingredient used in Baxter International Inc.'s recalled blood thinner heparin, as the agency sharply increased its count of the deaths potentially tied to the drug.

GE Healthcare a division of General Electric has  announced its role as the sole supplier of Magnetic Resonance Imaging (MRI) technology of the Beijing 2008 Olympic Games. Installed at the Olympic Village General Hospital, two of GE Healthcare’s advanced MRI technologies, the Signa HDe 1.5T will be accessible to be used on all international competing athletes during the Games.

Glaxo Smith Kline PLC has announced that it will stop selling one drug used to treat malaria and stop developing another because both appear to lower hemoglobin levels in the blood of some patients, which can lead to anemia.

Wyeth received Food and Drug Administration approval for its antidepressant Pristiq, keeping the company in a lucrative niche as a big-selling

Roche has announced , that its subsidiary Chugai Pharmaceutical Co. Ltd received approval from the Japanese Health Authority for the use of Herceptin in the early treatment for women with HER2-positive breast cancer.